ÂÜÀòÂÒÂ×

Chung Looi is an accomplished leader in life sciences with extensive experience across various roles. Currently serving as a Board Observer for OBN (UK) Ltd and Chief Executive Officer at Ablatus Therapeutics, Chung has led significant fundraising initiatives and contributed to shaping influential networks in the sector. Previous roles include Director of Strategic Partnerships at Monsenso, Director of Partnerships at OXFORD VR LIMITED, and Manager of Partnerships at Cambridge Cognition Plc, where Chung managed partnerships in neuroscience and digital health. Academic credentials include a DPhil in Experimental Psychology from the University of Oxford and a Graduate Diploma in Management from the London School of Economics, along with several other degrees in neuroscience and education. Chung's expertise encompasses neurotechnology, cognitive neuroscience, and the intersection of healthcare and technology, complemented by a history of leadership in academic and industry collaborations.